(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury. [electronic resource]
Producer: 20121126Description: 807-22 p. digitalISSN:- 1432-1912
- Animals
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- biosynthesis
- Behavior, Animal -- drug effects
- Catechin -- analogs & derivatives
- Desmin -- metabolism
- Foot -- physiology
- Hot Temperature
- Hyperalgesia -- drug therapy
- Immunohistochemistry
- Male
- Muscle, Skeletal -- metabolism
- Nerve Crush
- Neuroprotective Agents -- pharmacology
- Pain Measurement -- drug effects
- Posture -- physiology
- RNA -- biosynthesis
- Rats
- Rats, Wistar
- Reaction Time -- drug effects
- Real-Time Polymerase Chain Reaction
- Recovery of Function
- Sciatic Neuropathy -- drug therapy
- Signal Transduction -- drug effects
- Toes -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.